9.14% additional price slash against 776 NHI drugs.

Published: 2002-06-28 06:57:00

Updated: 2002-06-28 06:57:00

The MOHW intended to turn down the drug price additionally by 9.14% against 776 NHI drugs taking effect from July 1, but its enforcement time has not been determined due to different opinions postured by the KPhA.

In the 12th Health Insurance Policy Commission meeting on June 25 the MOHW decid...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK